Evolus director granted 45,559 RSUs
Malik Vikram reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Malik Vikram reported acquisition or exercise transactions in this Form 4 filing.
Evolus, Inc. director Vikram Malik reported an equity award of 45,559 shares of common stock in the form of restricted stock units (RSUs). Each RSU represents the right to receive one share of Evolus common stock for no cash payment.
The RSUs will vest in full on the one year anniversary of February 17, 2026, as long as Malik remains in continuous service, with accelerated vesting possible in certain change-of-control or similar events. After this grant, Malik beneficially owns 321,109 shares of Evolus common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 45,559 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Evolus (EOLS) director Vikram Malik report in this Form 4?
Is the Evolus (EOLS) Form 4 transaction a purchase or an award?
When do Vikram Malik’s new Evolus (EOLS) RSUs vest?
What is a restricted stock unit (RSU) in the Evolus (EOLS) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.